Drug Database
Back to search

Poland· PL-100250596

Levetiracetam ratiopharm

A levetiracetam product containing levetiracetamum, registered in Poland by ratiopharm GmbH. The same ATC class is registered in 19 of our 19 countries.

ATC N03AX14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLevetiracetam ratiopharmATCN03AX14REGISTER NO.PL-100250596PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levetiracetamumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levetiracetam is registered in 19 of 19 countries.

Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose
Search levetiracetam products by name

Levetiracetam · ATC N03AX14

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levetiracetam costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Levetiracetam · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$3.10
  • CH Switzerland$2.54
  • IT Italy$2.14
  • FR France$1.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Levetiracetamum
Manufacturer
ratiopharm GmbH
Country
Poland (PL)
ATC code
N03AX14
ATC class
Levetiracetam
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909990879786
  • gtin
    05909990879724
  • gtin
    05909990879731
  • gtin
    05909990879748
  • gtin
    05909990879755
  • gtin
    05909990879762
  • gtin
    05909990879779

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for levetiracetam.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levetiracetam against other medicinesHow interaction checks work

Levetiracetam · interactions on record

258 records

  • 50 moderate
  • 3 minor
  • 164 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N03AX14

Levetiracetam, as other registers publish it.

All levetiracetam products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d42261c1-2a6c-40fb-8f72-28e91b06a315
GET /v1/drugs/d42261c1-2a6c-40fb-8f72-28e91b06a315?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "750 mg",
  "packaging": "05909990879786 ¦ Rp ¦ EU/1/11/702/024 ¦ 67332\n200 tabl.\n05909990879724 ¦ Rp ¦ EU/1/11/702/018 ¦ 67445\n20 tabl.\n05909990879731 ¦ Rp ¦ EU/1/11/702/019 ¦ 67446\n30 tabl.\n05909990879748 ¦ Rp ¦ EU/1/11/702/020 ¦ 67447\n50 tabl.\n05909990879755 ¦ Rp ¦ Eu/1/11/702/021 ¦ 67448\n60 tabl.\n05909990879762 ¦ Rp ¦ EU/1/11/702/022 ¦ 67449\n80 tabl.\n05909990879779 ¦ Rp ¦ EU/1/11/702/023 ¦ 67450\n100 tabl.",
  "substance": null,
  "common_name": "Levetiracetamum",
  "pl_product_id": "100250596",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about levetiracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console